Claire Harrison, MD, DM, FRCP, FRCPath is a Professor of Hematology at the Guy’s and St. Thomas’ NHS Foundation Trust in London, UK. Prof. Harrison became a Consultant at the Guy’s and St. Thomas’ NHS Foundation Trust in 2001, where she is now a Clinical Director. The focus of her work is to improve diagnosis, risk definition and therapy of myeloproliferative neoplasms (MPNs), for which she has a national and international reputation.
Speaking on myeloproliferative neoplasms
Prof. Harrison is the chief investigator of several trials, including COMFORTII, the first JAK inhibitor trial in Europe. In 2011, she took over as Chair of the NCRI MPD group. Prof. Harrison works on translational work and clinical trials, and collaborates internationally with many centres including Addenbrooke’s, the Mayo Clinic and Mount Sinai. She also works in the field of blood transfusion and supports transfusion-based research.